Skip to main content
. Author manuscript; available in PMC: 2010 May 24.
Published in final edited form as: Urology. 2008 Apr 2;72(6):1234–1239. doi: 10.1016/j.urology.2007.12.060

Table 1.

Demographic, Clinical and Pathologic Characteristics for the 151 Patients

Variable Total (n=151) Relapse (n=47) Non-relapse (n=104) P value

Age (yrs)
 Mean (± SD) 58.5 (± 6.1) 58.8 (± 5.5) 58.3 (± 6.4) 0.703*
 Median (range) 59.0 (41 – 71) 59.0 (47 – 69) 60.0 (41 – 71)

Race
 Caucasian 141 (93.4) 43 (91.5) 98 (94.2) 0.503
 Non Caucasian 10 (6.6) 4 (8.5) 6 (5.8)

Clinical stage
 T1a 1 (0.7) 0 (0) 1 (1.0) 0.326
 T1b 4 (2.7) 1 (2.1) 3 (2.9)
 T1c 66 (43.7) 18 (38.3) 48 (46.1)
 T2a 44 (29.1) 16 (34.0) 28 (26.9)
 T2b 23 (15.2) 7 (14.9) 16 (15.4)
 T2c 11 (7.3) 4 (8.5) 7 (6.7)
 T3a 2 (1.3) 1 (2.1) 1 (1.0)

Preoperative PSA
 ≤ 4.01 27 (17.9) 3 (6.4) 24 (23.1) < 0.0001*
 4.0 – 10.0 80 (53.0) 15 (31.9) 65 (62.5)
 10.0 – 20.0 35 (23.1) 24 (51.1) 11 (10.6)
 > 20.0 9 (6.0) 5 (10.6) 4 (3.8)

Postoperative Gleason score
 0 - Gleason sum 5 5 (3.3) 0 (0) 5 (4.8) < 0.0001*
 1 - Gleason pattern 3+3 61 (40.4) 4 (8.5) 57 (54.8)
 2 - Gleason pattern 3+4 49 (32.4) 15 (31.9) 34 (32.7)
 3 - Gleason patter 4+3 16 (10.6) 13 (27.7) 3 (2.9)
 4 - Gleason sum 8–10 20 (13.3) 15 (31.9) 5 (4.8)

Extra capsular penetration
 No 82 (54.3) 9 (19.1) 73 (70.2) < 0.0001
 Yes 69 (45.7) 38 (80.9) 31 (29.8)

Surgical margin involvement
 No 117 (77.5) 27 (57.5) 90 (86.5) < 0.0001
 Yes 34 (22.5) 20 (42.5) 14 (13.5)

Lymph node involvement
 No 133 (88.1) 31 (66.0) 102 (98.1) < 0.0001
 Yes 18 (11.9) 16 (34.0) 2 (1.9)

Seminal vesicle involvement
 No 131 (86.7) 29 (61.7) 102 (98.1) < 0.0001
 Yes 20 (13.3) 18 (38.3) 2 (1.9)
*

Analyzed using t test or nonparametric Wilcoxon rank sum test for continuous data;

Numbers shown are frequencies with percentages in parentheses except for age.